JAM
JW Asset Management Portfolio holdings
AUM
$203M
This Quarter Return
-2.22%
1 Year Return
+14.62%
3 Year Return
+92.55%
5 Year Return
+369.07%
10 Year Return
+1,148.19%
AUM
$221M
AUM Growth
+$221M
(-8.7%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-5.09%
Top 10 Holdings %
Top 10 Hldgs %
99.57%
Holding
17
New
4
Increased
2
Reduced
1
Closed
4
Top Buys
| 1 |
Viking Therapeutics
VKTX
|
$2.85M |
| 2 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
$1.87M |
| 3 |
Alibaba
BABA
|
$1.59M |
| 4 |
NVIDIA
NVDA
|
$1.34M |
| 5 |
Five Below
FIVE
|
$442K |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$9.73M |
| 2 |
Eli Lilly
LLY
|
$7.7M |
| 3 |
Hims & Hers Health
HIMS
|
$1.31M |
| 4 |
Vita Coco
COCO
|
$566K |
| 5 |
Aspen Aerogels
ASPN
|
$358K |
Sector Composition
| 1 | Healthcare | 69.52% |
| 2 | Technology | 16.02% |
| 3 | Consumer Discretionary | 5.17% |
| 4 | Consumer Staples | 3.78% |
| 5 | Materials | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$1.2B
| $138M | 62.37% |
3,192,485
| – | – |
|
|
2
NVIDIA
NVDA
$4.24T
| $35.5M | 16.02% |
292,250
+11,000
| +4% | +$1.34M |
|
3
Abercrombie & Fitch
ANF
$4.46B
| $9.11M | 4.11% |
65,090
| – | – |
|
|
4
Vita Coco
COCO
$2.03B
| $8.37M | 3.78% |
295,621
-20,000
| -6% | -$566K |
|
5
Catalyst Pharmaceutical
CPRX
$2.52B
| $8.22M | 3.71% |
413,392
| – | – |
|
|
6
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $7.84M | 3.54% |
1,093,369
+261,086
| +31% | +$1.87M |
|
7
Heron Therapeutics
HRTX
$207M
| $4.56M | 2.06% |
2,292,418
| – | – |
|
8
Idaho Strategic Resources
IDR
$408M
| $4.37M | 1.97% |
271,697
| – | – |
|
|
9
Viking Therapeutics
VKTX
$3.04B
| $2.85M | 1.29% |
+45,000
| New | +$2.85M |
|
|
10
Alibaba
BABA
$322B
| $1.59M | 0.72% |
+15,000
| New | +$1.59M |
|
|
11
Five Below
FIVE
$8B
| $442K | 0.2% |
+5,000
| New | +$442K |
|
|
BBBY
12
Bed Bath & Beyond, Inc.
BBBY
$517M
| $302K | 0.14% |
+30,000
| New | +$302K |
|
|
HITI
13
High Tide
HITI
$292M
| $209K | 0.09% |
102,144
| – | – |
|
|
14
Aspen Aerogels
ASPN
$563M
| – | – |
-15,000
| Closed | -$358K |
|
|
15
Hims & Hers Health
HIMS
$9.57B
| – | – |
-65,000
| Closed | -$1.31M |
|
|
16
Eli Lilly
LLY
$657B
| – | – |
-8,500
| Closed | -$7.7M |
|
|
17
Novo Nordisk
NVO
$251B
| – | – |
-68,200
| Closed | -$9.73M |
|